BioSpace News Archive

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100 in advanced clinical development to treat COVID-19-induced respiratory disorders, reported that its collaboration partner, NRx Pharmaceuticals, Inc., has announced additional results from the aviptadil U.S. Expanded Access Protocol.

Core One Labs Inc. advises that in preparation of a potential listing of its common shares on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”), the Company is planning a share consolidation of its outstanding common share capital on the basis of eight (8) pre-Consolidation shares for every one (1) post-Consolidation share.

Regeneron Pharmaceuticals, Inc. welcomed positive results from the largest trial assessing any monoclonal antibody treatment in patients hospitalized with severe COVID-19.

curasan AG, a leading global provider of biomaterials for bone and tissue regeneration in dental and orthopedic surgery, and Xlife Sciences AG have initiated a collaboration in the field of regenerative medicine.

The growing technological advancement and increasing geriatric population will fuel the growth of the global x-ray detectors market.

The RNA analysis/transcriptomics market may gain immense growth across the assessment period of 2019-2029 on the back of the escalating advancements across the transcriptomics sector.

The gastric cancer drugs market is expected to garner exceptional growth during the forecast period of 2020-2030 on the back of the rising cases of gastric cancer across the globe.

Emergence of new liner materials such as polyurethane and thermoplastic elastomer pushing the sales of the prosthetic liners market

The antifungal drugs market is a very successful over-the-counter drug segment, in which robust generic competition is slated to rake in almost 65% to 70% of total market revenues in the near future.

Pascal Biosciences Inc., announced the appointment of Hardy Forzley as Chief Financial Officer.